A retrospective review found low-level light therapy (LLLT) successfully resolved recalcitrant chalazia in most patients who failed topical or systemic therapy, significantly reducing the need for surgery.

The study, published by Dovepress, reviewed a total of 26 eyes (22 patients) with chalazia that were unresponsive to previous pharmaceutical therapy or surgery. After two treatments, chalazia resolved in 92% of eyes (24/26).

Discussing the study in Ophthalmology Times, US-based ophthalmologist Dr Laura Periman also noted positive outcomes with intense pulsed light (IPL) for acute and chronic chalazia. “There is a natural marriage between IPL’s mechanisms of action and the underlying causes of chalazia. IPL has demodicidal, anti-inflammatory and anti-microbial, anti-telangiectatic properties, all of which address the inflammatory nature of chalazia.”